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A B S T R A C T
Background: The spread of the novel coronavirus (COVID-19) was declared a pandemic by the World Health
Organization on 11th March 2020. Since then there has been a rapid rise in development of maternal and
perinatal health guidelines related to COVID-19. The aim of this project was to develop a database of
Australian and international recommendations relating to antenatal, intrapartum and postpartum care of
women during the COVID-19 pandemic, in order to identify inconsistencies in clinical guidance.
Methods: Weconductedweeklywebsearchesfrom30thMarchto15thMay2020toidentifyrecommendations
pertaining to the care of women during pregnancy, labour and postpartum period from national or
international professional societies, specialist colleges, Ministries of Health, Australian state and territory
governments, and international guideline development organisations. Individual recommendations were
extracted and classified according to intervention type, time period, and patient population. Findings were
reported using descriptive analysis, with areas of consensus and non-consensus identified.
Results: We identified 81 guidelines from 48 different organisations. Generally, there was high consensus
across guidelines for specific interventions. However, variable guidancewas identified on the use of nitrous
oxide during labour, administration of antenatal corticosteroids, neonatal isolation after birth, labour and
birth companions, and the use of disease modifying agents for treating COVID-19.
Conclusion: Discrepancies between different guideline development organisations creates challenges for
maternity care clinicians during the COVID-19 pandemic. Collating recommendations and keeping up-to-date
with the latest guidance can help clinicians provide the best possible care to pregnant women and their babies.
© 2020 Australian College of Midwives. Published by Elsevier Ltd. All rights reserved.
Statement of significance
Problem or issue
In response to the COVID-9 pandemic, a large number of
maternal health guidelines have been rapidly produced.
Disagreements between guidelines can create uncertainties
for clinicians and health services.
What is already known
COVID-19 was declared a pandemic on 11th March 2020.
While there is limited evidence on the effects of COVID-19
on pregnant women and newborns, guideline develop-
ment organisations have rapidly produced antenatal,
intrapartum and postpartum care guidelines to assist
clinicians.
What this paper adds
This paper summarises the available maternal healthcare
guidelines released since the start of the COVID-19 pandemicAbbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2;
USA, the United States of America; UK, United Kingdom; PPE, personal protective
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In December 2019 a pneumonia of unknown cause was
etected in Wuhan, China and reported to the World Health
rganization [1]. The novel coronavirus, severe acute respiratory
yndrome coronavirus 2 (SARS-CoV-2) was found to be the
ausative agent, and the disease subsequently named COVID-19
2]. The World Health Organization declared the outbreak a
andemic on 11th March 2020. As of 9th July 2020, there have been
ver 11 million confirmed cases of COVID-19 globally, and over
40,000 deaths [3]. Available data on the effect of COVID-19 on
regnancy, pregnant women, and newborns is limited [4]. Current
nformation suggests pregnant women are not at higher risk of
evere illness than the general population [4]. A systematic review
dentified 33 studies which reported on the outcomes of 385
regnant women with COVID-19, of whom 368 (95.6%) were
onsidered to have mild disease [5]. Amongst 256 newborns the
revalence of preterm birth was 15.2% and low birth weight was
.8%. Eight (3.1%) newborns required admission to neonatal
ntensive care and 3 deaths occurred. The extent to which
aternal COVID-19 infection contributed to these perinatal
utcomes is unclear.
In the case of COVID-19 – a novel disease where new evidence is
merging daily – up-to-date clinical guidelines are vital in
roviding clinicians and other stakeholders with recommenda-
ions based on the latest available evidence. A considerable volume
f guidance relating to care of pregnant women with COVID-19 has
een rapidly developed and published. In some instances, clinical
ecommendations from different organisations are in conflict,
hich can create confusion for healthcare providers. We aimed to
evelop a database of national and international guidelines related
o the antenatal, intrapartum and postpartum care of women
uring the COVID-19 pandemic and identify those interventions
here there was high and low consensus across recommendations.
. Methods
.1. Literature search and eligibility assessment
We developed a study protocol to guide literature searching and
ata extraction. We aimed to identify and include any guidance
hat provided clinical recommendations or normative statements
elated to the clinical care of women during pregnancy, labour,
hildbirth or the postpartum period in the context of the COVID-19
andemic. Guidelines of interest were those developed specifically
n response to COVID-19, or where the recommendations
ertained to changes to routine care in the context of treating
OVID-19. We included guidelines produced either at internation-
l, national or Australian state or territory levels. Guidelines
roduced from reputable guideline development organisations
uch as national or international professional societies or specialty
olleges, Governmental departments or Ministries of Health or
nternational agencies were included. Guidelines published prior
o 2020 pertaining to other respiratory illnesses or infections were
ot eligible.
First, we developed a list of relevant guideline development
rganisations and searched their institutional websites directly.
his was supplemented with structured searches for clinical
uidelines via the Trip database, using the ‘guideline’ filter and
earch terms pregnancy, childbirth, postpartum (and related
Web visitors were invited to suggest additional guidelines or
resources for consideration via an online form.
2.2. Data extraction and management
All identified guidelines were initially screened by one reviewer
to assess eligibility. For eligible guidelines, each recommendation
pertaining to management of pregnancy, labour, childbirth and the
immediate postpartum period for women in the context of the
COVID-19 pandemic were extracted. Each guideline was reviewed
by two independent reviewers. Individual recommendations were
extracted and classified them according to intervention type,
period (preconception, antenatal, intrapartum, postpartum, all
periods, unspecified) and population (e.g. women, healthcare
providers or newborns). Recommendations for women and
newborns were classified differently depending on whether they
were regarding care of the general population, or specifically those
with suspected or confirmed COVID-19. Where one recommenda-
tion included the use of two (or more) interventions, it was
extracted twice (or more) and classified accordingly. Disagree-
ments between reviewers were resolved through discussion or
consultation with a third reviewer. If a guideline was updated, we
updated the data extraction accordingly, with superseded or
outdated recommendations removed from the database.
While standardised guideline quality assessment tools (such as
the AGREE II tool) exist, the majority of guidelines identified in our
searches were produced rapidly without the customary documen-
tation of the evidence synthesis and guideline development
process. This lack of information makes it difficult to properly (and
consistently) assess guideline quality. We therefore decided
against a formal quality assessment of individual guidelines. For
two guidelines that were not in English (French and Italian) we
used a combination of colleagues familiar with these languages
plus Google Translate to translate relevant recommendations into
English for analysis.
2.3. Data analysis
From the data we identified a list of 91 specific interventions,
grouped under 18 intervention types, for which at least one
recommendation was available. A full list of this interventions can
Box 1. Priority topics.
Provision of maternal health care during the COVID-19
pandemic
1. Models of care
2. Policies on visitors and support persons
3. Antenatal corticosteroids for preterm birth
4. Mode of birth
5. Pain management during labour
6. Cord clamping




Managing COVID-19 in pregnant women
10. Monitoring COVID-19 progression
11. Antibiotic treatment
12. Antivirals and other disease modifying agents13. Anticoagulants
14. Prone ventilation
15. Intubationerms) and COVID-19 [6].We also contacted international collabo-
ative networks to identify further eligible resources. For the
eriod of 30th March to 15th May 2020, weekly searches of all
dentified websites and Trip were conducted to identify new
uidelines or updates of existing guidelines. On 17th April 2020, we








The Royal Australian and New Zealand College of Obstetrics and
Gynaecology (RANZCOG)
6 119
Queensland Clinical Guidelines 2 71
New South Wales Health 2 46
Department of Health (Western Australia) 3 254
Australian Capital Territory Health 2 12
South Australia Health 1 15
Australian and New Zealand College of Anaesthetists (ANZCA) 1 6
Victorian Department of Health and Human Services 1 77
Department of Health Tasmania 2 18
Australasian Diabetes in Pregnancy Society (ADIPS), Australian Diabetes




Ministry of Health New Zealand 5 89
USA
Centers for Disease Control and Prevention (CDC) 2 23
The American College of Obstetricians and Gynecologists (ACOG) 4 109
Society for Obstetric Anesthesia and Perinatology (SOAP) 1 17
Society for Obstetric Anesthesia and Perinatology (SOAP); Society for
Maternal-Fetal Medicine (SMFM)
1 41
Society for Maternal-Fetal Medicine (SMFM) 2 35
Society for Maternal-Fetal Medicine (SMFM), The American College of
Obstetricians and Gynecologists (ACOG), American Academy of Family
Physicians (AAFP), American College of Nurse-Midwives (ACNM)
1 2
UK
Royal College of Obstetricians and Gynaecologists (RCOG) 6 227
Obstetric Anaesthetists’ Association (OAA) 1 14
Royal College of Paediatrics and Child Health (RCPCH) 1 28
Ireland
Institute of Obstetricians and Gynaecologists — Royal College of P
hysicians of Ireland (RCPI)
1 180
Canada
The Society of Obstetricians and Gynaecologists of Canada (SOGC) 1 26
Canadian Paediatric Society (CPS) 2 9
India
Federation of Obstetric and Gynaecological Societies of India (FOGSI) 1 70
The Phillipines
Philippine Obstetrical and Gynecological Society (POGS); Philippine Society
of Maternal Fetal Medicine (PSMFM)
1 40
Malaysia
Ministry of Health 1 12
Sri Lanka
Ministry of Health and Indigenous Medical Services 2 41
Italy
Società Italiana di Neonatologia (SIN) 1 21
France
Collège National des Gynécologues et Obstétriciens Français (CNGOF) 1 33
Spain
Federation of the Societies of Gynaecology and Obstetrics of the
Autonomous Communities of Spain
1 45
Belgium
Taskforce (ScienSano et al.) 1 9
International
World Health Organization (WHO) 1 19
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) 1 43
International Federation of Gynecology and Obstetrics (FIGO) 5 29
United Nations Population Fund (UNFPA) 3 114
Jhpiego 1 16
Inter-Agency Working Group on Reproductive Health in Crises (IAWG) 1 37
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35_). This list was reviewed and discussed by the review team, in
onsultation with three specialists in obstetrics, gynaecology and
idwifery, in order to identify a shortlist of priority topics (Box 1).
riority topics were those considered most important from a
linical care perspective and/or where lower consensus was
nticipated. We then prepared a detailed table of all recommen-
ations relating to this shortlist of priority topics. A narrative
ummary of each priority topic was prepared by the review team
ased on these findings, in order to qualitatively assess the degree
f consensus.
. Results
As of 15th May 2020, 81 unique guidelines pertaining to
regnancy, labour, childbirth and postpartum care from 48
ifferent organisations were identified (Table 1), all of which are
ublicly available via the Burnet Institute website [7]. Most of these
55/81) were state or national guidelines from Australia (21
uidelines) [8–28], New Zealand (five guidelines) [29–33] the
nited States of America (USA) (11 guidelines) [34–44], United
ingdom (UK) (eight guidelines) [45–52], Canada (three guide-
ines) [53–55], Sri Lanka (two guidelines) [56,57], and one
uideline from Ireland [58], Belgium [59], Malaysia [60], the
hilippines [61], India [62], Italy [63], France [64] and Spain [65].
here were 14 international guidelines from eight different
nternational organisations or societies [66–79] and nine guide-
ines from peer-reviewed journals [80,81,82,83,84,85,86,87,88].
uidelines were issued by state or national governments (21
uidelines), national speciality societies (obstetric, anaesthetic,
nfectious disease or paediatric; 37 guidelines), international
ocieties (eight guidelines) and United Nations organisations (five
uidelines). In total, 71 guidelines were published on websites and
en were published in peer-reviewed journals. All guidelines were
ublished between 2nd March and 13th May. In total, 81 guidelines
ad 2205 recommendations for interventions regarding pregnan-
y, childbirth and postpartum care (though some recommenda-
ions were counted twice, where they pertained to two different
nterventions). The number of recommendations per guideline
anged from two [42] to 180 [58].
. Provision of maternal healthcare during the COVID-19
women during the COVID-19 pandemic. These included recom-
mendations pertaining to attending or postponing appointments
(63 recommendations), face-to-face visits (57 recommendations),
and the use of telehealth (88 recommendations). There was
general consensus that face-to-face visits should be minimised in
favour of telehealth and home visits where possible. Several
guidelines recommended the number of face-to-face visits be
reduced, such as by grouping components of care together
[4,10,30,31,37,46,49,66,71,75], and both antenatal and postnatal
care should be redirected to telehealth or home visits where
possible [4,10,16,17,21,23,25,30,31,37,41,45,48,58,61,66,71,75,76].
Additionally, there was consensus that women who are well
should attend appointments which require a face-to-face visit and
should not be deterred from presenting to hospital if concerned
about their pregnancy [23,45,46,48,58,78]. One guideline from Sri
Lanka [56] suggested that routine antenatal and postnatal care
should only be conducted for specific groups of women and
newborns with complications. Some guidelines stated the time
taken for these appointments and for physical examination should
be limited to minimise the risk of infection transmission [4,17,23–
25,30,31,66]. There was general consensus that face-to-face visits
should be delayed for women in self-isolation or with respiratory
symptoms [13,17,21,23,31,37,45,48,53,58,61,66,74,75] and that
screening should occur prior to all visits to identify women who
are unwell [17,23,37,38,46,75].
4.2. Policies on visitors and support persons during antenatal visits
and childbirth
There were 87 recommendations across 40 guidelines (from 28
organisations) regarding the presence of a support person and
birth and appointments for all pregnant women, and infection
control policies for these visitors. There was general consensus that
the number of visitors for women in hospital should be restricted,
with some guidelines suggesting a limit of one visitor per day
[4,8,10,13,16,17,19–21,23–25,30,34,40,45,56,65,66,71,81]. Four
guidelines – Western Australia [18], India [62], Italy (Capanna
et al. [87]) and the USA [35] – suggested that women with
suspected or confirmed COVID-19 should not be allowed visitors.
Other recommendations for minimising the risk of infection
transmission included preventing young children from visiting






International Planned Parenthood Federation (IPPF) 1 6
Peer-reviewed journals
Dashraath et al. (Singapore) [83] 1 25
Chen et al. (China) [81] 1 37
Qi et al. (International) [82] 1 24
Chawla et al. (India) [80] 1 44
Baud et al. (International) [85] 1 9
Schmid et al. (International) [84] 1 5
Favre et al. (International) [86] 1 26
McIntosh (USA) [88] 1 7
Capanna et al. (Italy) [87] 1 46
International Federation of Gynecology and
Obstetrics & allied partners
1 91andemic
.1. Models of care
There were 239 recommendations from 43 guidelines (origi-
ating from 29 organisations) regarding models of care for all4
one regular support person rather than rotating through numerous
visitors [13,23], and enforcing regular hand hygiene and appropri-
ate Personal Protective Equipment (PPE) for all visitors and
patients [10,17,23,40,45,65,66,80].
There was no consensus between guidelines regarding birth
companions. Eight guidelines indicated that women – irrespective
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companion present, provided the companion is asymptomatic
[13,18,45,50,58,62,66]. However, three guidelines from Sri Lanka
[57], Italy (Capanna et al. [87]) and FIGO and allied partners [75]
advised that no birth partners should be allowed for women with
suspected or confirmed COVID-19. There was consensus that
individuals who are symptomatic or confirmed to have COVID-19
should not be allowed to visit a hospital [4,10,13,23,54,66,80] and
that all support persons should be screened prior to presenting to a
facility [34,40,45,66,80]. Regarding appointments, some guide-
lines stated it is preferable that women attend alone, however if
necessary for support or care then a maximum of one visitor may
be allowed [18,25,47,48,61,66].
4.3. Antenatal corticosteroids for preterm birth
There were 29 guidelines from 27 organisations which provided
37 recommendations regarding the use of antenatal corticoste-
roids (both betamethasone and dexamethasone) for preterm birth
in women with COVID-19 infection. There was disagreement
between guidelines as to whether corticosteroids should be given
when usually recommended. While some guidelines recom-
mended that steroids should be given where usually indicated
[8,13,23,45,52,53,57,65,66,81], others suggested there should be
more careful assessment of the balance between maternal risks
and neonatal benefit, and that it should be discussed with
maternal-fetal, neonatal and infectious disease specialists in light
of evidence suggesting harm to the patient with severe COVID-19
[35,61,62,64,73–75,77,83,85,87,88]. Three guidelines from West-
ern Australia [17], Queensland [13] and Ireland [58] recommended
that while COVID-19 infection itself is not an indication to alter the
provision of antenatal corticosteroids, in those with moderate to
severe disease the administration of antenatal corticosteroids
should be discussed with specialists in light of the maternal risks.
Two guidelines from the USA [37,44] suggested that antenatal
corticosteroids could be given up until 34 weeks’ gestation, as at
later gestations the benefits may not outweigh the potential risks
to a COVID-19 positive patient with moderate to severe disease.
4.4. Mode of birth
There were 115 recommendations from 38 guidelines (32
organisations) regarding the mode of birth for women with COVID-
19. The majority of these were regarding the decision between a
caesarean or vaginal birth (53 recommendations). Others per-
tained to instrumental birth, induction of labour, the timing of
birth and guidelines for performing a caesarean section such as PPE
and the number of theatre staff.
There was general consensus that the mode of birth should not
be influenced by maternal COVID19, unless urgent birth is required
due to the mother’s respiratory condition [4,8,10,13,17,21,23,37,44,
45,57–59,61,62,64,73–81]. In the case of rapid maternal deterio-
ration, guidelines advise an individual assessment and treatment
of the patient [17,45,87] and caesarean section may be required
[10,75,83,86]. Alternatively, if the woman delivers vaginally and is
short of breath, some guidelines suggest instrumental birth may be
required to shorten the length of the second stage of labour
[8,74,75,86]. However, two guidelines suggested that there may be
a greater need for caesarean section in COVID-19 positive women
— Qi et al. [82] suggested that the threshold for a caesarean should
however delaying elective caesarean section and induction of
labour could be considered [8,53,61]. Despite suggesting that
COVID-19 infection alone is not a reason to expedite birth, Qi et al.
[82] recommended that if COVID-19 infection is not improved by
treatment, early birth should be considered even in absence of
obstetric indications (no justification was provided for this).
4.5. Pain management
There were 26 guidelines from 23 different organisations which
offered 80 recommendations regarding labour analgesia for all
women including regional and general anaesthesia (45 recom-
mendations), water immersion/birthing pools (10 recommenda-
tions) and nitrous oxide (23 recommendations).
There was disagreement between guidelines as to whether to
use nitrous oxide. Several guidelines suggested that given the
insufficient information as to whether or not nitrous oxide is an
aerosol generating procedure it should be avoided in women with
suspected or confirmed COVID-19 [4,12,13,17,22,33,60]. Others
suggested that nitrous oxide was safe to give all pregnant women,
provided it was used with a single-patient microbiological filter
[10,23,45,51,58]. One guideline from the UK indicated that nitrous
oxide use was not an aerosol-generating procedure, however it did
not provide a recommendation as to its safety in COVID-19-
positive women [52]. Other guidelines from the USA indicated that
its use and potential suspension should be discussed within
individual labour and delivery units [34,35,37], or that it may be a
source of cross-infection, and that it is important staff are aware of
the appropriate decontamination guidelines [83].
There was consensus that regional anaesthesia should continue
to be used normally [4,8,12,22,34,45,51,62]. Although both
regional and general anaesthesia may be considered
[74,75,81,82], regional anaesthesia is preferred to general anaes-
thesia, unless it is unavoidable [22,51,57,58,60,75]. Several guide-
lines indicated that early epidural anaesthesia in labour should be
considered to minimise need for general anaesthesia
[12,13,17,23,35,45,51,58], and also as an alternative to nitrous
oxide in women who are COVID-19 positive [12]. Three guidelines
indicated that in women with COVID-19 the platelet count should
be checked prior to spinal/epidural, considering that thrombocy-
topenia is a common finding in people with COVID-19 [22,51,58].
When general anaesthesia is used, guidelines recommend it should
be done under negative pressure [45], by experienced anaesthe-
tists with adequate PPE [57,58].
There was general consensus that birthing pools (i.e. giving
birth while immersed in water) should be avoided in women with
COVID-19 due to the risk of infection to the newborn and
healthcare workers [13,17,23,45,58,74,75]. However, RANZCOG
[4,12] has indicated that water immersion may continue to be used
in the normal manner. It is unclear as to whether this
recommendation also includes women who are COVID-19 positive.
4.6. Delayed umbilical cord clamping
There were 20 guidelines from 18 organisations which gave 23
recommendations regarding cord clamping. There was no consen-
sus between guidelines surrounding whether delayed cord
clamping is appropriate in women with COVID-19. While many
guidelines suggest that delayed cord clamping safe to continue
given the lack of evidence to suggest otherwise [8,12,13,17,23,37,be lower. A Malaysian guideline [60] suggested that infected
women should be offered caesarean section until there is further
information on the safety of vaginal birth, however this guideline
had not been updated since 24 March 2020.
There was general consensus that maternal COVID-19 infection
alone is not a reason to expedite birth [13,44,58,65,74,75,81,82],5
45,52,53,85], others recommended it may be best avoided
[58,65,74,75,80,81,83,87]. One guideline from Ireland [58] sug-
gested that delayed cord clamping might be appropriate for
preterm neonates less than 32 weeks’ gestation, but should not be
routinely done for babies born at a later gestation. Favre et al. [86]
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owever, Schmid et al. [84] suggested this recommendation was
armful when applied to the general population, stating that
ertical transmission of SARS-CoV-2 is uncommon.
. Essential newborn care for babies born to women with
OVID-19
.1. Skin-to-skin contact for the newborn
There were 21 recommendations in 17 guidelines (from 16
rganisations) regarding skin-to-skin contact between mothers
nd newborns after birth. There was consensus that skin-to-skin
hould continue regardless of maternal COVID-19 infection,
rovided appropriate PPE is worn [12,15,17,23,31,52–54,
6,73,76]. However, guidelines from Spain [65], Singapore
Dashraath et al. [83]), Ireland [58], India (Chawla et al. [80])
nd Italy (Capanna et al. [87]) recommended that early skin-to-
kin contact be avoided in mothers with COVID-19, although they
id not provide evidence that skin-to-skin transmission of COVID-
9 occurs.
.2. Rooming in for mother and baby
In total, 32 guidelines (27 organisations) gave 67 recommen-
ations on this topic. There was lower consensus regarding
hether or not, in the presence of maternal COVID-19, rooming in
hould be used. Most indicated that the newborn should not be
eparated from the mother, regardless of maternal COVID-19
tatus, unless in the case of severe maternal or newborn illness
8,10,13,15,17,23,45,53,54,58,63,66,74,75,78]. However, some
uidelines from the USA, as well as China (Chen et al.) and Favre
t al. recommended separation to prevent maternal-infant
ransmission [34,35,81,86]. Others from the USA, FIGO and Baud
t al. suggested separation should be considered on a case-by-case
asis, with full involvement of the mother [38,40,41,71,85]. One
uideline from India (Chawla et al. [80]) suggested that rooming-in
e undertaken for stable neonates, but if there are available
esources for isolation then separation should be favoured. It was
uggested that in the event of rooming-in, when a mother has
OVID-19, measures should be taken to reduce transmission, for
xample using PPE or a curtain between mother and newborn and
ttention to strict hand hygiene measures [35,40,58,71,74,75].
.3. Breastfeeding
In total, 52 guidelines from 41 different organisations had 121
ecommendations related to breastfeeding. There was consensus
hat breastfeeding is safe and important to continue, regardless of
he woman’s COVID-19 status, and if a woman was well enough to
reastfeed she should be encouraged to do so [8,10,12–15,17,19,
1,23,29,31,41,45,53,54,56,58,62–64,66,67,71,73,76,78–80]. How-
ver, three guidelines from Malaysia [60], China (Chen et al. [81])
nd Favre et al. [86] advised against direct breastfeeding in
others with COVID-19, however no evidence was provided to
upport these recommendations.
Several guidelines indicated that while there is currently no
vidence that the virus can be transmitted through breastmilk, there
sariskof transmissionfrommothertobabyduringbreastfeedingvia
espiratory droplets. Guidelines consequently emphasised the need
due to maternal COVID-19 infection, they should still be
encouraged to express milk which can safely be provided to
their newborn [10,15,17,23,29,39,54,58,62,63,66,67,71,73–76,80].
One guideline from the UK [52] suggested that given the
overwhelming benefits of breast milk to the infant, unwell
COVID-19 positive women who are required to withhold
breastfeeding are encouraged to express their breastmilk and
discard it in order to maintain lactation until she is no longer
infectious.
6. Managing pregnant women with COVID-19 disease
6.1. Monitoring COVID-19 progression
There were 28 guidelines (from 26 different organisations)
which gave 93 recommendations regarding caring for pregnant
women with COVID-19. These pertained to hospital admission (22
recommendations), fluid balance monitoring (21 recommenda-
tions) and target oxygen saturation (29 recommendations). There
was consensus that pregnant women who had COVID-19 infection
with moderate or severe disease or respiratory complications or
compromise should be admitted to hospital for management
[43,44,64,71,86]. Two guidelines specified that criteria should be
in place for transferring women to a centre with Intensive Care Unit
facilities [62,86] and one guideline indicated there should be a
lower threshold for transferring vulnerable groups of patients to
such facilities [10].
There was general consensus that given the association of fluid
overload and Acute Respiratory Distress Syndrome, women with
moderate and severe disease require close fluid balance monitor-
ing [8,13,17,45,58,66,75]. Several noted critically ill pregnant
patients without shock should be managed with conservative
fluid management [74,81]. Additionally, there was consensus that
oxygen saturations should be monitored closely
[17,45,74,75,80,81] and hypoxia should be avoided, with the aim
of maintaining target oxygen saturation >92%
[8,13,44,45,57,58,74,75,80,81]. However, there was some variation
on the actual target level of oxygen saturation (>92–95%). One
guideline from the USA specified that while the recommended
target oxygen saturation for nonpregnant women with COVID-19
is >92%, for pregnant women oxygen saturation should aim for
>95% [44].
6.2. Antibiotics for treating women with COVID-19
There were 27 recommendations in 15 guidelines from 15
different organisations regarding antibiotic use. There was general
consensus that antibiotics should only be commenced in women
with COVID-19 if there was evidence of secondary bacterial
infection [17,53,58,61,62,65,74,75,81,89], and that antibiotic ther-
apy should be discussed with infectious diseases specialists
[13,17,64,74,75]. However, three guidelines from India [62,80]
and the Philippines [61] suggested that azithromycin could be used
for the specific treatment of COVID-19, however there is no
evidence to support these recommendations.
6.3. Antivirals and other disease modifying treatments for women with
COVID-19
Eleven guidelines (11 organisations) made 27 recommenda-
or mothers with suspected or confirmed COVID-19 to wear a
ace mask and to practice hand hygiene while breastfeeding
8,9,16,17, 23,29,31,35,38,40,41,45,46,53,54,56,58,59,62,63,66,67,
1,73–75, 79–81,83,85].
Additionally, there was consensus that if women are not well
nough to breastfeed, or if temporary separation is undertaken6
tions regarding antiviral and other disease modifying treatments
for COVID-19. Some guidelines specified that the use of antivirals in
a pregnant woman with COVID-19 must be done in consultation
with a virologist prior to initiating therapy and on a case-by-case
basis [65,74,75]. Others gave suggestions regarding possible
dosing regimens for hydroxycholoroquine [58,59,62,80,83],
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mivir [62] and the immunosuppressive agent tocilizumab [58].
6.4. Anticoagulants for women with COVID-19
Six guidelines (five organisations) provided 17 recommenda-
tions regarding anticoagulation for COVID-19 positive pregnant
patients. Most recommended that both antenatal and postnatal
venous thromboembolism prophylaxis be considered for pregnant
women with COVID-19 irrespective of disease severity
[13,45,58,75], while two recommended that all COVID-19-positive
women be discharged home postnatally with prophylactic low
molecular weight heparin [45,58]. Others recommended venous
thromboembolism prophylaxis needs to be considered on a case-
by-case basis [44,58].
6.5. Prone ventilation
We identified four recommendations from four guidelines
regarding prone ventilation in pregnant women. Two indicated
that while prone ventilation is strongly recommended in adults
with severe Acute Respiratory Distress Syndrome, there is little
evidence on prone position in pregnant women, and in this case
the lateral decubitus position may be more beneficial [62,73]. One
suggested that prone positioning may not be feasible in pregnancy
but should be considered in early (pre-viable) gestations [58],
however another stated prone positioning was indeed feasible in
pregnancy and could be used in addition to the lateral decubitus
position [44].
6.6. Intubation
There was limited guidance regarding the use of intubation in
pregnant women (five recommendations from three guidelines). It
was suggested that the timing of intubation should be individual-
ised [44], with another guideline recommending early intubation
for pregnant women whose respiratory function deteriorates [65].
Another guideline stated pregnant women were at risk of
aspiration requiring early intubation [58].
One guideline suggested that in pregnant women, mechanical
ventilation may not be sufficient for severe respiratory failure and
extracorporeal membrane oxygenation may have a role [65]. Two
other recommendations also referred to the use of extracorporeal
membrane oxygenation — One guideline from the USA advised its
use be discussed if expedited birth was being considered for severe
hypoxaemia [44], and another from China (Chen et al.) recom-
mended its use be limited during pregnancy with less invasive
measures used beforehand [81].
7. Discussion
7.1. Key findings
We identified a large and growing volume of maternal and
perinatal health guidelines related to COVID-19 over a six-week
period. We identified limited consensus amongst guideline
development organisations regarding key maternal and newborn
health interventions, including nitrous oxide during labour,
policies on birth companions, rooming-in, antenatal corticoste-
roids, anticoagulants and the use of antivirals and other disease
7.2. Strengths and limitations
Our review has included a large number of guidelines from a
range of different organisations worldwide. Through weekly
checks, we closely monitored updates to pre-existing recommen-
dations and guidelines and were able to identify key areas of
disagreement. A limitation to this review is the pace at which
guidance is being updated, given the emergence of new informa-
tion and evidence regarding COVID-19 and its impacts on women
and newborns. Many guidelines were regularly updated, and in
several instances, recommendations were significantly changed or
removed entirely. This makes it difficult for clinicians and health
services to stay up-to-date with best practice.
Additionally, we were limited in our ability to translate
guidelines and there were few guidelines reviewed in languages
other than English.
7.3. Interpretation and implications
Two recent publications by Cochrane Pregnancy and Childbirth
[90] and Narang et al. [91] considered a range of maternal and
perinatal health guidelines related to the COVID-19 pandemic. The
Cochrane report, which focused on guidelines in a subset of
countries with more than 10,000 cases of COVID-19 on 19th April,
similarly found a lack of consensus in the use of antenatal steroids,
the use of nitrous oxide, policies on birth companions and
rooming-in, as well as skin-to-skin contact and breastfeeding —
two interventions for which our review found more general
consensus. Narang et al. considered 15 papers from 10 professional
societies available on 20th April 2020 and reported inconsistencies
in guidelines regarding the provision of antenatal corticosteroids.
These differences can largely be attributed to scope (our review
considered a wider range of countries and guidelines) and time
period of interest (considering guidelines are being produced and
updated rapidly, however they similarly indicate the presence of
conflicts in clinical guidance internationally. The limited consensus
we identified for some recommendations – such as anticoagula-
tion, nitrous oxide and birth companions – identify where further
research would assist clinicians in their practice in COVID-affected
settings.
Our review represents a snapshot in time of the current
guidelines and recommendations available up until 15th May 2020
and we acknowledge that some recommendations may have been
updated or altered. These changes may reflect new evidence on the
benefits and possible harms of using some interventions in the
context of COVID-19. While it is important for guidelines to be
updated rapidly in response to new evidence, this creates further
challenges for clinicians in staying up-to-date. In the past few
years, “living guidelines” have emerged as a model for ensuring
recommendations remain up-to-date in light of new evidence [92].
In the living guidelines approach, literature is monitored on an
ongoing basis, with systematic reviews, evidence profiles and
recommendations updated in response to changes in the
underlying evidence. Living guideline approaches have been
applied in guidelines for maternal and perinatal health, stroke
and diabetes [93–95]. In March 2020, the National COVID-19
Clinical Evidence Taskforce (https://covid19evidence.net.au/) was
established in Australia to provide healthcare professionals with
living guidelines on the clinical care of people with COVID-19. This
review was conducted as part of the preparatory activities tomodifying agents. Available guidelines were produced rapidly in
the context of the COVID-19 pandemic, generally in the absence of
direct evidence. Given the frequency of updates, it is difficult for
clinicians and services to stay up-to-date with the most recent
guidance.7
support the Pregnancy and Perinatal Care Panel of the Taskforce,
which first convened on 14th May 2020. Since then, the Taskforce
has issued a series of recommendations on mode of birth,
breastfeeding and rooming-in, as well as recommendations the
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regnant and postpartum women. These recommendations will be
pdated in response to new evidence and are expanding to include
ther prioritised interventions.
. Conclusion
Maternal and newborn health guidance has been rapidly
roduced in response to the COVID-19 pandemic. Our review
dentified 81 unique guidelines from 48 different organisations
elated to the antenatal, intrapartum and postpartum care of
omen during the pandemic. We found lower consensus between
uidelines regarding nitrous oxide during labour, policies on birth
ompanions, rooming-in, antenatal corticosteroids, anticoagulants
nd the use of antivirals and other disease modifying agents. Due to
he large number of guidelines being produced as well as these
reas of disagreement, it can be difficult for clinicians to determine
ow best to care for pregnant and postpartum women in the
ontext of COVID-19. This review provides a summary of available
ecommendations to help guide clinicians and health services, as
ell as other maternal and perinatal health guideline developers.
iven the rapidly evolving nature of the situation and the changes
hat have already occurred since our review in May 2020, it is vital
hat health workers seek out the latest guidance when making
linical decisions.
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